Increased Prevalence of theGCM2Polymorphism, Y282D, in Primary Hyperparathyroidism: Analysis of Three Italian Cohorts
Author(s) -
Leonardo D’Agruma,
Michela Coco,
Vito Guarnieri,
Claudia Battista,
Lucie Canaff,
Antonio Stefano Salcuni,
Sabrina Corbetta,
Filomena Cetani,
Salvatore Minisola,
Iacopo Chiodini,
Cristina Eller-Vainicher,
Anna Spada,
Claudio Marcocci,
Giuseppe Guglielmi,
Michele Zini,
Rosanna Clemente,
Betty Wong,
Danilo de Martino,
Alfredo Scillitani,
Geoffrey N. Hendy,
David E.C. Cole
Publication year - 2014
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2014-2857
Subject(s) - primary hyperparathyroidism , cohort , transactivation , endocrinology , missense mutation , medicine , hyperparathyroidism , biology , gastroenterology , genetics , phenotype , gene , gene expression
Glial cells missing-2 (GCM2) is key for parathyroid gland organogenesis. Its persistent expression in the adult parathyroid raises the possibility that overactive forms play a role in the evolution of parathyroid hyperactivity or tumorigenesis. A GCM2 c.844T → G; p.Y282D missense variant has been described within a transactivation inhibitory domain (amino acids 263-352).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom